JPMorgan reiterated its preference for domestic over Asia-exposed U.K. banks, “given the risks on US tariffs and ...

President Trump’s aim to slash U.S. prescription drug prices by 50% is unlikely to materialize, according to analysts at ...

ING noted the ECB sees the recent disinflation as “mainly transitory due to energy prices and the stronger euro.” Still, ING ...

Jefferies upgraded Southern Company (NYSE: SO) to Buy from Hold, citing stronger-than-expected long-term earnings growth ...

Tesla (NASDAQ: TSLA) shares fell 7% following President Donald Trump’s public criticism of the company and its CEO, Elon Musk ...

Huawei Technologies has emerged as NVIDIA Corporation’s (NASDAQ: NVDA) most high-profile rival in the race to power ...

Investing.com -- Mizuho upgraded Visa Inc (NYSE: V) to Outperform from Neutral and raised its price target to $425 from $359, ...

Investing.com -- BofA Global Research reiterated its bearish stance on the U.S. dollar in a note Thursday, even as it ...

The brokerage forecasts Dr Reddy’s semaglutide revenues at $280 million in 2027, contributing about 18% of the company’s ...

Securities said the Bank of Canada’s decision to hold its policy rate at 2.75% reflects a wait-and-see approach amid ...

Apple’s attempt to pause a lower court ruling that forces it to allow third-party payment links in its App Store was denied ...

Investing.com -- Brown-Forman Corp missed Wall Street estimates for first-quarter earnings and revenue and warned of a tough ...